TRDA
Entrada Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Dipal Doshi
IPO Date
2021-10-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Entrada Therapeutics, Inc.
CEO
Dipal Doshi
IPO Date
2021-10-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 25,907 |
| $15.39 |
| 4 May 2026 | Dowden Nathan J | President & COO | M-Exempt | Acquired | 15,000 | $1.74 |
| 4 May 2026 | Dowden Nathan J | President & COO | S-Sale | Disposed | 15,000 | $15.33 |
| 4 May 2026 | Dowden Nathan J | President & COO | M-Exempt | Disposed | 15,000 | $1.74 |
| 2 Apr 2026 | WENTWORTH KORY JAMES | Chief Financial Officer | S-Sale | Disposed | 2,500 | $12.95 |
| 11 Mar 2026 | Dowden Nathan J | President & COO | S-Sale | Disposed | 3,116 | $13.02 |
| 11 Mar 2026 | Dowden Nathan J | President & COO | S-Sale | Disposed | 11,894 | $13.05 |
| 11 Mar 2026 | WENTWORTH KORY JAMES | Chief Financial Officer | S-Sale | Disposed | 5,089 | $13.00 |
| 11 Mar 2026 | WENTWORTH KORY JAMES | Chief Financial Officer | S-Sale | Disposed | 11,388 | $13.02 |